🎯Patients with a positive mpMRI (PI-RADS ≥3) but negative target & systematic biopsies still face risks of prostate cancer (26.8%) and clinically significant prostate cancer (19.3%). Follow-up strategies matter! 📈
🔹 Best outcomes: repeat mpMRIs + biopsy based on clinical/radiological triggers (96% csPCA-free at 2 yrs).
🔹 Predictors: age, prostate volume, PI-RADS score, ASAP, & biopsy core count
Tailored follow-up is essential for managing these high-risk cases. 👨⚕️📊 #ProstateCancer #mpMRI #Urology
https://t.co/e5T2FmWdrz @EAU_YAUProstate@EAUYAUrology
The debate surrounding nerve-sparing Radical Prostatectomy for HRPCa persists due to the delicate equilibrium needed between heightened risks of positive margins and the potential functional advantages. KUDOS @Lara__Rodriguez and @eau_yuo, LEADING THE WAY.
🎉 Exciting News! 📚 The final version of our article, "Primary Whole Gland Ablation for The Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement," is now published! 🚀 Check it out: https://t.co/El9JQ6N57M #FocalTherapy
Surgery in high risk prostate cancer:
- better symptom control
- less need for ADT
- seems to provide better overall survival vs. EBRT + Brachytherapy in younger patients (no RCT)
@adamkibel_uro @BWHUrology
Según la evidencia científica, aquellos pacientes que son operados en el día de cumpleaños del cirujano/a presentan una mortalidad mayor que si se operaran cualquier otro día.
Por este motivo, hoy he decidido tomarme el día libre.
Al final, todos hemos salido ganando.
Double j catheter in a #holep
This reminds us that not everything is wonderful, there are complications and we have to know how to solve them.
At the end of the day the patient is perfect, he was discharged ambulatory and in 3 weeks I will remove his catheter.
#aeep#eep #urobruce
Holep number 246